- Audsley J, Avihingsanon A, Littlejohn M, Bowden S, Matthews G, Fairley CK, Lewin SR, Sasadeusz J. Progressive HBsAg loss in HIV-HBV coinfected individuals on TDF-inclusive cART.
- Carr A, Grund B, Schwartz AV, Avihingsanon A, Badal-Faesen S, Bernadino JI, Mallon PW, Estrada V, La Rosa AM, Pujari S, White D, Wyman-Engen N, Ensrud KE, Hoy J. Rates of bone loss slow after the first year of aRT: START BMD substudy final results.
- Carr A, Richardson R, Kerr SJ, Ebeling PR, Pocock N, Rojas J, Martinez E, Hoy J. Greater bone turnover marker decline with zoledronic acid than with TDF-switching (ID494).
- Chattranukulchai P, Tumkosit M, Siwamogsatham S, Apornpong T, Gatechompol S, Hiransuthikul A, Han WM, Kerr SJ, Putcharoen O, Boonyaratavej S, Ruxrungtham K, Phanuphak P, Avihingsanon A. Coronary artery calcification in virologically suppressed aging HIV-infected Thais.
- Cressey TR, Tan S, Said HRHM, Hassan MRA, Omar H, Poh TH, Kheong CW, Kumar S, Thongsawat S, Thetket K, Khemnark S, Avihingsanon A, Simon F, Andrieux-Meyer I, Lallemant M. Ravidasvir pharmacokinetics and ARV drugs interactions in HCV+/-HIV infected adults.
- Fujitnirun C, Manosuthi W, Gatechompol S, Pingsusaen P, Thammajaruk N, Colbers A, Aarnoutse R, Ruxrungtham K, Burger DM, Avihingsanon A, Putcharoen O. Pharmacokinetics of rifabutin 150 mg QD vs 300 mg TIW with LPV/r in HIV/TB patients.
- Kityo C, Hagins D, Koenig E, Avihingsanon A, Chetchotisakd P, Supparatpinyo K, Gankina N, Pokrovsky V, Voronin E, Stephens JL, DeJesus E, Wang H, Quirk E, Martin H, Makadzange T. Switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in women.
- MacDonald D, Collins G, Ingraham N, Melzer A, Crothers K, Avihingsanon A, Mugerwa H, Ristola M, Shuter J, Kunisaki K. Smoking and accelerated lung function decline in the start pulmonary substudy.
- Wattanachanya L, Jantarapakde J, Avihingsanon A, Ramautarsing R, Kerr SJ, Trachunthong D, Mansawat T, Pussadee K, Teeratakulpisarn N, Jadwattanakul T, Chaiwatanarat T, Phanuphak N, Sunthornyothin S, Phanuphak P. ARV naïve HIV-infected adults had lower bone formation markers than HIV-uninfection.